Corient Private Wealth’s LifeMD LFMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$62.6K Hold
15,167
﹤0.01% 2975
2026
Q1
$54.8K Buy
15,167
+167
+1% +$578 ﹤0.01% 2753
2025
Q4
$51.1K Sell
15,000
-140
-0.9% -$680 ﹤0.01% 2596
2025
Q3
$103K Sell
15,140
-1,007
-6% -$8.32K ﹤0.01% 2439
2025
Q2
$220K Buy
16,147
+1,007
+7% +$9.51K ﹤0.01% 2180
2025
Q1
$82.4K Hold
15,140
﹤0.01% 2188
2024
Q4
$74.9K Hold
15,140
﹤0.01% 2252
2024
Q3
$79.3K Buy
15,140
+85
+0.6% +$490 ﹤0.01% 2358
2024
Q2
$103K Buy
15,055
+55
+0.4% +$503 ﹤0.01% 2211
2024
Q1
$154K Hold
15,000
﹤0.01% 2135
2023
Q4
$124K Hold
15,000
﹤0.01% 2137
2023
Q3
$93.8K Hold
15,000
﹤0.01% 2026
2023
Q2
$65.3K Hold
15,000
﹤0.01% 2004
2023
Q1
$25.5K Hold
15,000
﹤0.01% 1967
2022
Q4
$29.1K Buy
+15,000
New +$33.6K ﹤0.01% 1658

Other funds holding LFMD

Corient Private Wealth's LFMD Position: Q2 2026 in Review

Corient Private Wealth held its LifeMD (LFMD) position steady in Q2 2026 at 15,167 shares worth $62.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2975.

Corient Private Wealth first reported a position in LFMD in Q4 2022 and has held it in 15 quarters since. The position peaked at $220K in Q2 2025. 115 funds tracked by Wall St. Rank hold LFMD as of Q2 2026.

  • Corient Private Wealth held 15,167 shares of LifeMD worth $62.6K as of Q2 2026.
  • Corient Private Wealth left its LifeMD share count unchanged in Q2 2026.
  • LifeMD made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #2975 holding.
  • Corient Private Wealth first reported a position in LifeMD in Q4 2022 and has held it in 15 quarters since.
  • Corient Private Wealth's LifeMD position peaked at $220K in Q2 2025.
  • 115 funds tracked by Wall St. Rank held LifeMD as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.